


Searching News Database: RG2833
HSMN NewsFeed - 24 May 2010
Repligen Receives Orphan Drug Designation from the FDA for RG2833 for Friedreich's Ataxia
Repligen Receives Orphan Drug Designation from the FDA for RG2833 for Friedreich's Ataxia
